EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cholesterol–LXR axis in metabolic regulation of liver fibrosis and hepatocarcinogenesis

Elena Piccinin, Gaetano Villani, Antonio Moschetta

Trends in Endocrinology & Metabolism · 2026-11 · 37 (11) · 1063-1077

DOI: 10.1016/j.tem.2026.03.011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2026-11. Verfasst von Elena Piccinin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari 'Aldo Moro', Bari, Italy. Hauptthemen laut MEDLINE: Liver X Receptors, Liver Neoplasms, Cholesterol, Liver Cirrhosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Ministero dell'Istruzione dell'Università e della Ricerca, Ministry of Health, Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease is increasing worldwide, and its progression to metabolic dysfunction-associated steatohepatitis (MASH) and ultimately hepatocellular carcinoma (HCC) remains a major clinical challenge. In this review, we discuss the role of liver X receptors (LXRs), transcriptional regulators of fatty acid synthesis, and cholesterol balance, which play an apparently paradoxical metabolic role: while their activation increases lipogenesis, driving steatosis, their inhibition leads to harmful cholesterol buildup and inflammation, central to the pathogenesis of MASH and HCC. In HCC, disrupted LXR signalling prevents cholesterol efflux, fuelling tumour growth. Therapeutic strategies targeting LXRs must therefore be stage-specific and cell type-specific to avoid worsening liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver X ReceptorsLiver NeoplasmsCholesterolLiver CirrhosisCarcinoma, HepatocellularHumansAnimalsFatty LiverSignal Transduction

Stichwörter der Autor:innen

cholesterol metabolismfibrosishepatocellular carcinomaliver X receptor (LXR)metabolic liver disease

Substanzen

Liver X ReceptorsCholesterol

Autor:innen und Institutionen

  • Department of Translational Biomedicine and Neuroscience (DiBraiN), University of Bari 'Aldo Moro', Bari, Italy.
  • Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Bari 70124, Italy; National Institute of Biostructures and Biosystems (INBB), Viale delle Medaglie d'Oro 305, Roma 00136, Italy. Electronic addre…

Förderung

  • Ministero dell'Istruzione dell'Università e della Ricerca
  • Ministry of Health
  • Ministero dell'Università e della Ricerca
  • European Commission
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Piccinin, E., Villani, G., & Moschetta, A. (2026). Cholesterol–LXR axis in metabolic regulation of liver fibrosis and hepatocarcinogenesis. Trends in Endocrinology & Metabolism, 37(11), 1063-1077. https://doi.org/10.1016/j.tem.2026.03.011

Vancouver

Piccinin E, Villani G, Moschetta A. Cholesterol–LXR axis in metabolic regulation of liver fibrosis and hepatocarcinogenesis. Trends in Endocrinology & Metabolism. 2026;37(11):1063-1077. doi:10.1016/j.tem.2026.03.011

BibTeX
@article{Piccinin2026,
  author = {Piccinin, Elena and Villani, Gaetano and Moschetta, Antonio},
  title = {Cholesterol–LXR axis in metabolic regulation of liver fibrosis and hepatocarcinogenesis},
  journal = {Trends in Endocrinology & Metabolism},
  year = {2026},
  volume = {37},
  number = {11},
  pages = {1063--1077},
  doi = {10.1016/j.tem.2026.03.011}
}
Kostenlos starten →